Bringing you the latest news, features and guidance advice from NICE NICE News
April 2012
Bringing you the latest news, features and guidance from NICE
New guidance
 
 

First oral therapy for MS approved by NICE

 
 

Patients with relapsing remitting multiple sclerosis can now be offered a pill that helps reduce the number of relapses.Fingolimod (Gilenya) is the first pill-based medicine for MS and works by preventing white blood cells from attacking nerve cells in the brain and spinal cord.

 

 

Read more  
 
 

New drugs "a major benefit" for patients with chronic hepatitis C 

 
 

NICE has recommended the use of boceprevir (Victrelis) and telaprevir (Incivo), both in combination with peginterferon alfa and ribavirin, as options for the treatment of the most common strain of hepatitis C in adults, in latest guidance.

Read more  
 
Also this month
 
 

Improving the mental health of prisoners

NICE will develop guidance aimed at improving the mental health of people in prison, following the latest topic referral from the Department of Health. It is estimated that around 90 per cent of all prisoners have a diagnosable mental health problem, including personality disorders, and/or a substance misuse problem.

 

 
  Read more  
 
Also this month
 
 

Latest Fellows and Scholars unveiled

Exploring the use of NICE guidance by out-of-hours GPs, promoting NICE in dentistry, and investigating whether childhood activity guidelines are being followed in schools, are just some of the projects planned by the latest group of fellows and scholars. NICE has awarded 11 fellowships and 10 scholarships to professionals working in the NHS, social care and public health.

 

 
  Read more  
 
Into practice
 
 

New quality standards for lung cancer and hip fracture

The lung cancer standard consists of 15 quality statements to improve the care of people with the cancer. For example, people presenting with symptoms should be referred within 1 week of presentation for a chest X-ray.

 

The hip fracture standard includes 14 quality statements which encompass the whole hip fracture pathway.

 

 

 

 

 
  Read more  
 
New guidance
 
 

Have your say on preliminary recommendations that say that bevacizumab in combination with capecitabine is not recommended, within its licensed indication, for the first-line treatment of metastatic breast cancer.

 

 

Read more  
 
 

NICE has carried out a review and updated its guidelines manual, which explains how the Institute develops and updates clinical guidelines.It provides advice on the technical aspects of clinical guideline development and the methods used. Let us know what you think of the update.

 

Read more